Skip to main content

Table 1 Demographic characteristics of outpatients diagnosed with migraine

From: Trends and prescribing patterns of antimigraine medicines in nine major cities in China from 2018 to 2022: a retrospective prescription analysis

 

2018

2019

2020

2021

2022

Total

P1

P2

Outpatient visits

6217

6766

5418

6748

7097

32,246

0.462

–

Age (years)

        

 <30

1036 (16.66)

1037 (15.33)

896 (16.54)

1204 (17.84)

1244 (17.53)

5417 (16.80)

0.221

0.003

 30–39

1191 (19.16)

1340 (19.80)

1224 (22.59)

1601 (23.73)

1630 (22.97)

6986 (21.66)

0.086

<  0.001

 40–49

1295 (20.83)

1290 (19.07)

1021 (18.84)

1275 (18.89)

1345 (18.95)

6226 (19.31)

1.000

0.014

 50–59

1175 (18.90)

1318 (19.48)

1016 (18.75)

1202 (17.81)

1285 (18.11)

5996 (18.59)

0.807

0.029

 60–69

840 (13.51)

1027 (15.18)

719 (13.27)

848 (12.57)

905 (12.75)

4339 (13.46)

0.807

0.001

  ≥ 70

647 (10.41)

709 (10.48)

504 (9.30)

564 (8.36)

619 (8.72)

3043 (9.44)

0.807

<  0.001

sex

        

 male

1912 (30.75)

2006 (29.65)

1603 (29.59)

1892 (28.04)

1890 (26.63)

9303 (28.85)

0.462

<  0.001

 female

4021 (64.68)

4511 (66.67)

3575 (65.98)

4551 (67.44)

4950 (69.75)

21,608 (67.01)

0.221

<  0.001

  1. P1, P value for the trend in the number of outpatient visits, assessed by the Mann–Kendall trend test; P2, P value for the trend in the proportion of outpatient visits, assessed by the Cochran–Armitage trend test. The number of outpatient visits for each year is the denominator of the data in that column